PLPL Stock | Buy or Sell? | News | Quote | Stock Forum | Friday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$PLPL Plandai Biotechnology, Inc. PLPL Company Overview 

PLPL Overall Average: 40% Buy

Stock Message Board http://investorshangout.com/search?q=PLPL&...mp;yt1=Go!

Last Updated: Friday, December 13, 2013 11:31:21 PM

Plandai Biotechnology, Inc. PLPL Current Price and Quotes
Last Price 0.45
Previous Close 0.44 Open 0.44
Daily Range 0.46 - 0.4101 52wk Range 0.82 - 0.04
Volume 39,400 Dividend N/A
Average Vol (3m) 132,467 Yield N/A
Plandai Biotechnology, Inc. PLPL
Company Information

2226 Eastlake Avenue East
#156
Seattle, WA 98102
Australia

Website: http://www.plandaibiotech.com
Phone: 435-881-8734
Email: info@plandaibiotech.com

Plandai Biotechnology, Inc. PLPL
Planda Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market.
In November 2011, Planda Biotechnology, Inc. through its wholly-owned subsidiary acquired 100% ownership of Global Energy Solutions Corporation Limited (GES), through a share exchange.
Since 2002, GES successfully conducted documented research producing extracts from a variety of l...



Plandai Biotechnology, Inc. PLPL
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001317880
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 200 a/o Dec 01, 2012
Company Officers/Contacts

Roger Duffield CEO
Company Directors

Not Available
Company Notes

Formerly=Diamond Ranch Foods, Ltd. until 1-2012
Formerly=Jerry's, Inc. until 5-04. Jerry's, Inc. (FL) merged into Jerry's, Inc. (NV) prior to tha name change
Service Providers

Auditor/Accountant
Michael F. Cronin, CPA
1574 Eagle Nest Circle
Winter Springs, FL, 32708
United States

Legal Counsel
Mcgowan & Daniels
10004 Wurzbach Rd
San Antonio, TX, 78230
United States

Investor Relations Firm
Redwood Consultants, LLC
250 Bel Marin Keys Bldg.
Novato, CA, 94949
United States


Plandai Biotechnology, Inc. PLPL
PLPL Security Details

Share Structure

Market Value1 $47,844,342 a/o Dec 13, 2013
Shares Outstanding 106,320,760 a/o Nov 01, 2013
Float Not Available
Authorized Shares 500,000,000 a/o Dec 31, 2011
Par Value  0.0001
Shareholders

Shareholders of Record 299 a/o Sep 30, 2013
Security Notes

Capital Change=shs decreased by 1 for 50 split Pay date=05/13/2004.
Capital Change=shs decreased by 1 for 2000 split. Pay date=09/19/2008.
Short Selling Data

Short Interest 196,848 (1.19%)
Nov 29, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Signature Stock Transfer, Inc.

Plandai Biotechnology, Inc. PLPL Financials

Plandai Biotechnology, Inc. PLPL Recent News

Dec 12, 2013 Plandai Biotechnology's CEO Discusses Direction of Medical Marijuana Subsidiary
Dec 11, 2013 Plandai Biotechnology, Inc. Announces Intellectual Property Filings
Dec 9, 2013 Plandai Biotechnology, Inc. to Focus Marijuana Research on Neuron Disorders Including Alzheimer's, Parkinson's, and Multiple Sclerosis
Nov 26, 2013 Plandai's Medical Marijuana Research Could Benefit From FDA Approval of Clinical Trials
Nov 20, 2013 Plandai to Provide New Formula in Diet Industry Profit Quest
Nov 19, 2013 New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
Nov 14, 2013 Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
Nov 1, 2013 Plandai Enters Medical Marijuana Market
Oct 31, 2013 Plandai Biotechnology Enters Medical Marijuana Arena With Industry-Changing Technology
Oct 30, 2013 Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract

1
2
next >
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 392

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 404

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 346

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 181

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 103

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 337

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Prudent Growth Partners Expands with Castle Shops Acquisition

Updated Category News Views 174

Prudent Growth Partners Enhances Retail Portfolio Prudent Growth Partners, LLC, a well-established private equity real estate firm, has recently made a significant leap forward by acquiring Castle Shops for $5.4 million. This 37,309 square foot retail center is situated in a bustling area, presenting exciting opportunities for growth and development. Strategic Location of...

Continue Reading
TOYO Co., Ltd Unveils Ambitious Solar Manufacturing Project

Updated Category News Views 220

TOYO Co., Ltd Unveils Plans for Solar Manufacturing Facility TOYO Co., Ltd (NASDAQ: TOYO), a leading company specializing in solar solutions, is thrilled to reveal its plans for a cutting-edge solar cell manufacturing facility. This new plant is expected to have an impressive annual capacity of 2 gigawatts (GW), reflecting TOYO's commitment to advancing renewable energy...

Continue Reading
Future Trends in the AI Semiconductor Ecosystem Explained

Updated Category News Views 331

Understanding the AI Semiconductor Ecosystem The AI semiconductor ecosystem is evolving rapidly, a movement driven largely by the increasing need for computational power essential for artificial intelligence advancements. This sector has reached a pivotal point where the demand for AI-powered solutions, especially large language models, significantly exceeds current chip...

Continue Reading
Broadwind Set to Release Year-End 2024 Results Soon

Updated Category News Views 199

Broadwind's Upcoming Financial Results Announcement Broadwind (Nasdaq: BWEN), a leading precision manufacturer known for its specialized components and solutions, has exciting news. They are set to announce their financial results for the fourth quarter and full year of 2024. This important update will occur before the market begins on a scheduled day. Conference Call...

Continue Reading
Snowflake Stock Earnings Rollercoaster: The Good and Bad

Updated Category News Views 305

Rocky Road for Snowflake: Earnings Highlights Turn the lights on, folks. Right when you thought Snowflake was ready to soar, the stock pulled some classic market gymnastics. This company just reported a fourth-quarter revenue of $1.28 billion, which isn't just pocket change; that’s $50 million over what the analysts were slinging around, estimating a mere $1.26 billion...

Continue Reading